Lu S#, Tong X#, Han Y#, Zhang K, Zhang Y, Chen Q, Duan J, Lei X, Huang M, Qiu Y, Zhang DY, Zhou X, Zhang Y*,Yin H*, Fast and sensitive detection of SARS-CoV-2 RNA using suboptimal protospacer adjacent motifs for Cas12a,Nature Biomedical Engineering, 2022 Mar;6(3):286-297
Wang J#, He Z#, Wang G#, Zhang R#, Duan J, Gao P, Lei X, Qiu H, Zhang C, Zhang Y,Yin H*, Efficient targeted insertion of large DNA fragments without DNA donor,Nature Methods,2022 Mar;19(3):331-340.
Wang L#, Xue W#, Zhang H#, Gao R#, Qiu H#, Wei J, Zhou L, Lei YN, Wu X, Li X, Liu C, Wu J, Chen Q, Ma H, Huang X, Cai C, Zhang Y, Yang B*,Yin H*, Yang L*, Chen J*,Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations.NatureCell Biology. 2021 May;23(5):552-563.
Song CQ#,Jiang T#,Richter M,Rhym LH,Koblan LW,Zafra MP,Schatoff EM,Doman JL,Cao Y,Dow LE,Zhu LJ,Anderson DG,Liu DR*,Yin H*,Xue W*,Adenine base editing in an adult mouse model of tyrosinaemia.Nature Biomedical Engineering.2020 Jan;4(1):125-130.
专文评述:Nature Biomedical Engineering“Correcting tyrosinaemia via a point mutation”
Nature Biomedical Engineering“Towards better base editing”
F1000推荐
Lu S#, Li F#, Chen Q, Wu J, Duan J, Lei X, Zhang Y, Zhao D, Bu Z*,Yin H*,Rapid detection of African swine fever virus using Cas12a-based portable paper diagnostics，Cell Discovery，2020 volume 6:18
Yin H*,Xue W*,Anderson DG*CRISPR-Cas: a tool for cancer research and therapeutics.Nature Reviews Clinical Oncology.2019 May;16(5):281-295.
入选Nature庆祝基因编辑荣获2020年诺贝尔奖的百篇论文选集
Chen Q, Zhang Y*,Yin H*,Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing.Advanced Drug Delivery Reviews2021 Jan;168:246-258
Wu J,Yin H*. Engineering guide RNA to reduce the off-target effects of CRISPR.Journal of Genetics and Genomics.2019 Nov 20;46(11):523-529.
Zhang HX,Zhang Y*,Yin H*.Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9.Molecular Therapy.2019 Apr 10;27(4):735-746
Yin H#, Song CQ#, Suresh S, Kwan SY, Wu Q, Walsh S, Ding J, Bogorad RL, Zhu LJ,Wolfe SA, Koteliansky V, Xue W, Langer R, Anderson DG，Partial DNA-guided Cas9 enables genome editing with reduced off-target activity.Nature Chemical Biology.2018, 14(3):311-316.
专文评述:Nature Catalysis “Better guidance is cheaper”
BioCentury | Altering Cas9 and its guide for fewer off-target edits.
入选Nature庆祝基因编辑荣获2020年诺贝尔奖的百篇论文选集
Yin H, Song CQ, Suresh S, Wu Q, Walsh S, Rhym LH, Mintzer E, Bolukbasi MF, Zhu LJ, Kauffman K, Mou H, Oberholzer A, Ding J, Kwan SY, Bogorad RL, Zatsepin T, Koteliansky V, Wolfe SA, Xue W, Langer R, Anderson DG. Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing.Nature Biotechnology2017, 35(12):1179-1187.
*媒体报道：Featured by VOICE of America / US Researchers Use Nanotech, Gene Editing to Edit Cholesterol Gene VICE / CRISPR Can Now Edit Genes Using Nanoparticles Instead of Viruses Yahoo News / CNBC / Nanotech, gene editing used to edit cholesterol gene-US study/ Genetic Engineering & Biotechnology News / CRISPR/Cas9 Delivery Goes Nano with Enhanced Guide RNA Fiercebiotech / MIT scientists propose a safer way to edit genes with CRISPR / MIT News / Science Daily / Bioscience Technology / Medical News Today/Business Insider UK / The Medical News / Phys.org.
F1000推荐
Yin H, Kauffman KJ and Anderson DG.Delivery technologies for genome editing.Nature Reviews Drug Discovery2017, 16(6): 387-399.
Yin H, Song CQ, Dorkin JR, Zhu L, Li Y,Wu Q, Park A, Yang J, Suresh S, Bizhanova A, Gupta A, Bolukbasi M, Walsh S, Bogorad R, Gao G, Weng Z, Dong Y, Koteliansky V, Wolfe S, Langer R, Xue W and Anderson DG. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.Nature Biotechnology2016,34(3):328-33.
*媒体报道：Featured by MIT News / Science Daily / Bioscience Technology / Medical News Today / Deutsches Ärzteblatt / Nanowerk / Nanotechnology Now /The Medical News / Phys.org
Yin H#, Bogorad RL#, Barnes C, Walsh S, Zhuang I, Nonaka H, Ruda V, Kuchimanchi S, Nechev L, Akinc A, Xue W, Zerial M, Langer R, Anderson DG, Koteliansky V. RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.Journal of Hepatology2016, 64(4):899-907.
Mou H, Kennedy Z, Anderson DG,Yin H*, and Xue W*, Precision cancer mouse models through genome editing with CRISPR-Cas9.Genome Medicine2015, 7(1):53.
Yin H#, Xue W#, Chen S, Bogorad RL, Benedetti E, Grompe M, Koteliansky V, Sharp PA, Jacks T, Anderson DG (2014) Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.Nature Biotechnology2014, 32(6):551-3.
*100 top stories of 2014 by Discover Magazine as “A Giant Step for Gene Surgery”
*Top Ten Genetics Stories for 2014: Incredible Achievements, by the DNA Exchange
*专文评述: Nature Medicine (CRISPR technology for gene therapy)|封面故事Science–Business eXchange of Nature Publishing Group | BioTechniques
*媒体报道：Featured by MIT News /英国独立报头版报道/ Fox News / The Times of India / Science Daily / Medical daily / The Voice of Russia / Phys.org /
F1000推荐
入选Nature庆祝基因编辑荣获2020年诺贝尔奖的百篇论文选集
Xue W#, Chen S#,Yin H#,Tammela T, Joshi N, Papagiannakopoulos T, Cai W, Yang G, Bronson R, Crowley D, Zhang F, Anderson DG, Sharp PA, Jacks T. CRISPR-mediated direct mutation of cancer genes in the mouse liver.Nature2014, 514(7522):380-4.
*专文评述:Hepatology (Cutting short the path to murine liver cancer models)
*媒体报道:Featured by MIT News / Science Daily / Medical Press / Newswise / F1000Prime Recommendation.
Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG. Non-viral vectors for gene-based therapy.Nature Reviews Genetics2014, 15(8):541-55.
Bogorad RL#,Yin H#, Zeigerer A, Nonaka H, Ruda VM, Zerial M, Anderson DG, Koteliansky V Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice.Nature Communications2014, 5:3869.
*专文评述:Nature Reviews Gastroenterology & Hepatology(Loss of integrin β1 impairs liver regeneration and HCC progression)
Yin H, Cheng L, Holt M, Hail N, Jr., Maclaren R, Ju C, “Lactoferrin protects against acetaminophen-induced liver injury in mice”,Hepatology2010, doi: 10.1002/hep.23476.
Yin H, Cheng L, Langenbach R, Ju C, “Prostaglandin I(2) and E(2) mediate the protective effects of cyclooxygenase-2 in a mouse model of immune-mediated liver injury”,Hepatology2007, doi: 10.1002/hep.21493.
